Clinical Trials List
Protocol Number206207-008-01
Not yet recruiting
2006-09-01 - 2007-12-31
Phase III
-
Trial Applicant
ALLERGAN PHARMACEUTICALS TAIWAN CO., LTD.
-
Sponsor
-
Trial scale
-
Update
2026/07/01
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
650 participants
